[The effectiveness of treating patients with coronary insufficiency with verapamil].
D000136:Acid-Base Equilibrium; D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001775:Blood Circulation / Q000187:drug effects; D001783:Blood Flow Velocity; D002302:Cardiac Output / Q000187:drug effects; D002306:Cardiac Volume / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy*; D004562:Electrocardiography; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007511:Ischemia; D008297:Male; D008875:Middle Aged; D009570:Nitriles / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy; D012039:Regional Blood Flow / Q000187:drug effects; D014665:Vasodilator Agents / Q000627:therapeutic use*; D014700:Verapamil / Q000494:pharmacology / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D009570:Nitriles; D014665:Vasodilator Agents; D014700:Verapamil
Zur Frage der Wirksamkeit einer Behandlung von coronarinsuffizienten Patienten mit Verapamil.